Barry J Lamphear
Overview
Explore the profile of Barry J Lamphear including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayden C, Streatfield S, Lamphear B, Fake G, Keener T, Walker J, et al.
Vaccine
. 2012 Mar;
30(19):2937-42.
PMID: 22406456
Hepatitis B remains a major global health problem despite the availability of a safe and effective vaccine. Segments of the population lack access to or respond poorly to the parenteral...
2.
Lamphear B, Barker D, Brooks C, Delaney D, Lane J, Beifuss K, et al.
Plant Biotechnol J
. 2006 Dec;
3(1):103-14.
PMID: 17168903
The availability of foods low in sugar content yet high in flavour is critically important to millions of individuals conscious of carbohydrate intake for diabetic or dietetic purposes. Brazzein is...
3.
Lamphear B, Jilka J, Kesl L, Welter M, Howard J, Streatfield S
Vaccine
. 2004 Jun;
22(19):2420-4.
PMID: 15193404
Recombinant plant expression systems offer a means to produce large quantities of selected antigens for subunit vaccines. Cereals are particularly well-suited expression vehicles since the expressed proteins can be stored...
4.
Streatfield S, Lane J, Brooks C, Barker D, Poage M, Mayor J, et al.
Vaccine
. 2003 Jan;
21(7-8):812-5.
PMID: 12531366
The synthesis of selected antigens in plants and their oral delivery has great potential for reducing the costs of vaccine production and administration. The application of this technology requires antigen...
5.
Lamphear B, Streatfield S, Jilka J, Brooks C, Barker D, Turner D, et al.
J Control Release
. 2002 Dec;
85(1-3):169-80.
PMID: 12480322
The use of recombinant gene technologies by the vaccine industry has revolutionized the way antigens are generated, and has provided safer, more effective means of protecting animals and humans against...
6.
Zhao X, Lamphear B, Xiong D, Knowlton K, Rhoads R
J Biol Chem
. 2002 Dec;
278(7):4449-57.
PMID: 12475969
The shutoff of host protein synthesis by certain picornaviruses is mediated, at least in part, by proteolytic cleavage of eIF4G-1. Previously, we developed a cleavage site variant of eIF4G-1, termed...
7.
Stachelska A, Wieczorek Z, Ruszczynska K, Stolarski R, Pietrzak M, Lamphear B, et al.
Acta Biochim Pol
. 2002 Nov;
49(3):671-82.
PMID: 12422237
Translation initiation factor eIF4E binds the m(7)G cap of eukaryotic mRNAs and mediates recruitment of mRNA to the ribosome during cap-dependent translation initiation. This event is the rate-limiting step of...